ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,127.79
0.00%
US Tech 100
17,484.38
0.37%
Dow Jones
38,675.68
0.00%
Brent Oil
83.465
0.41%
Bitcoin
63,378.38
-0.97%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Remy Cointreau SA (RCO) Quote

Remy Cointreau SA

Remy Cointreau SA (RCO)

Royalco Resources Limited
91.45
1.20
( 1.33% )
Updated: 08:38:42
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
91.45
Bid
91.35
Ask
91.40
Volume
8,832
90.25 Day's Range 91.65
86.98 52 Week Range 163.15
Market Cap
4.69B
Previous Close
90.25
Open
90.85
Last Trade
7
@
91.45
Last Trade Time
08:37:23
Financial Volume
-
VWAP
-
Average Volume (3m)
90,126
Shares Outstanding
51,252,969
Dividend Yield
2.19%
PE Ratio
15.96
Earnings Per Share (EPS)
5.73
Revenue
1.55B
Net Profit
293.8M

About Remy Cointreau SA

Sector
Wine,brandy & Brandy Spirits
Industry
Beverages
Website
www.remy-cointreau.com
Headquarters
Saintes, Charente-maritime, Fra
Founded
1975
Remy Cointreau SA is listed in the Wine,brandy & Brandy Spirits sector of the Euronext with ticker RCO. The last closing price for Remy Cointreau was 90.25 €. Over the last year, Remy Cointreau shares have traded in a share price range of 86.98 € to 163.15 €.

Remy Cointreau currently has 51,252,969 shares outstanding. The market capitalization of Remy Cointreau is 4.69 € billion. Remy Cointreau has a price to earnings ratio (PE ratio) of 15.96.

RCO Latest News

More News

Rémy Cointreau: FY 2023-24 sales: -19.2% on an organic basis

Strong sequential improvement in sales in Q4: -0.7 % 2023-24 COP margin guidance confirmed China: significant growth in Q4 sales, boosted by positive phasing effects and good resilience of Rémy...

April 26 2024
Business Wire

Rémy Cointreau renouvelle avec succès sa ligne de crédit syndiqué, portée à 180 M€

Regulatory News: Rémy Cointreau (Paris:RCO) annonce le renouvellement avec succès de sa ligne de crédit syndiqué « RCF1 » pour un montant porté à 180 millions d’euros et une durée de 5 ans...

April 02 2024
Business Wire

Remy Cointreau: INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL A LA DATE DE PUBLICATION DE L’AVIS DE REUNION DE L’ASSEMBLEE GENERALE MIXTE DU 20 JUILLET 2023

Article L.233-8 II du Code de Commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers Regulatory News: Remy Cointreau (Paris:RCO): Code ISIN : FR0000130395 NOMBRE D'ACTIONS...

March 21 2024
Business Wire

Remy Cointreau : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL A LA DATE DE PUBLICATION DE L’AVIS DE REUNION DE L’ASSEMBLEE GENERALE MIXTE DU 20 JUILLET 2023

Article L.233-8 II du Code de Commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers Regulatory News: Remy Cointreau (Paris:RCO): Code ISIN : FR0000130395 NOMBRE D'ACTIONS...

March 08 2024
Business Wire

Remy Cointreau: Information on the Total Number of Voting Rights and Shares Forming the Share Capital on the Date of Publication of the Meeting Notice of the Combined General Meeting of July 20, 2023

Article L.233-8 II of the French commercial code and with Article 223-16 of the General Regulation of the Financial markets Authority (AMF – Autorité des marchés Financiers) Regulatory News: Remy...

March 08 2024
Business Wire

Rémy Cointreau: Third-quarter 2023-24 sales: -23.5% on an organic basis

2023-24 full-year guidance confirmed Sequential improvement in the United States, driven by positive phasing effect Major destocking in China ahead of the Chinese New Year  Solid execution of...

January 26 2024
Business Wire

Shares in European Drinks Makers Drop on China Investigation

By Andrea Figueras Shares in European drinks makers tumbled on Friday after the Chinese government launched an anti-dumping investigation into brandy imported from the European Union in an...

January 05 2024
Dow Jones News

REMY COINTREAU : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL A LA DATE DE PUBLICATION DE L’AVIS DE REUNION DE L’ASSEMBLEE GENERALE MIXTE DU 20 JUILLET 2023

Article L.233-8 II du Code de Commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers Regulatory News: Remy Cointreau (Paris:RCO): Code ISIN : FR0000130395 NOMBRE D'ACTIONS...

December 15 2023
Business Wire

Notification de mise à disposition par Rémy Cointreau de son rapport financier semestriel 2023-24

Regulatory News: En date de ce jour, Rémy Cointreau (Paris:RCO) indique avoir mis à disposition du public son rapport financier semestriel pour la période close le 30 septembre 2023, disponible...

November 30 2023
Business Wire

European Stocks Drop as Spirit-Makers Lag; Oil Gains -- Market Talk

1733 GMT -- European stocks fall as losses for drinks and luxury-goods shares offset gains for oil and arms companies. The Stoxx Europe 600, FTSE 100 and CAC 40 drop about 1% and the DAX retreats...

November 10 2023
Dow Jones News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
11.952.1787709497289.591.8588.38461889.67175534DE
43.453.920454545458898.5587.48981491.36050369DE
12-7.29-7.3830261292398.74102.887.49012693.69249302DE
26-25.15-21.5694682676116.6116.7586.9810588999.06629516DE
52-70.8-43.6363636364162.25163.1586.9894817114.88570548DE
156-76.45-45.5330553901167.9217.286.9881579151.17783807DE
260-26.35-22.3684210526117.8217.279.286042139.40791719DE

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TCBPTC BioPharm Holdings PLC
$ 2.90
(98.63%)
494.05k
XBPXBP Europe Holdings Inc
$ 4.21
(98.58%)
15.94M
PRFTPerficient Inc
$ 73.65
(53.09%)
322.37k
DUOTDuos Technologies Group Inc
$ 3.95
(28.66%)
5
TELOTelomir Pharmaceuticals Inc
$ 7.90
(27.42%)
5
LYRALyra Therapeutics Inc
$ 0.29
(-92.80%)
3.12M
GLYCGlycoMimetics Inc
$ 0.4199
(-77.05%)
4.47M
AFIBAcutus Medical Inc
$ 0.0859
(-40.64%)
435.28k
MMATMeta Materials Inc
$ 2.39
(-28.66%)
41.25k
EYPTEyePoint Pharmaceuticals Inc
$ 14.30
(-27.56%)
330.84k
XBPXBP Europe Holdings Inc
$ 4.21
(98.58%)
15.94M
FFIEFaraday Future Intelligent Electric Inc
$ 0.0419
(2.44%)
9.12M
ALLRAllarity Therapeutics Inc
$ 1.21
(21.00%)
7.31M
SBFMSunshine Biopharma Inc
$ 0.951
(13.21%)
5.95M
GLYCGlycoMimetics Inc
$ 0.4199
(-77.05%)
4.47M

Discussion

View Full Feed
BigBadWolf BigBadWolf 4 minutes ago
Authorized Shares 12,000,000,000 05/03/2024
Outstanding Shares 4,292,898,447 05/03/2024
Restricted 586,331,747 05/03/2024
Unrestricted 3,706,566,700 05/03/2024
Held at DTC 3,425,562,735 05/03/2024

Authorized Shares 12,000,000,000 05/02/2024
Outstandi
DTC
GARYM1 GARYM1 5 minutes ago
We at least get to fight another day.
It also means we can see how much demand there actually will be for S7 products.
No more excuses ,go out and sell something to anybody please
SEV
samson8 samson8 5 minutes ago
Kinda weird timing that this chartmaster guy is now all of a sudden posting on GMZP and INKW. 2 Steve Carnes stocks. Probably getting paid to promote it like they always do.
GMZP INKW
infamous infamous 5 minutes ago
i understand this is considered a quiet period. however, there are lots of things they CAN tell us.
EBET
jedijazz jedijazz 5 minutes ago
$NRXP NEWS OUT: @NRxPharma NRx Pharmaceuticals (Nasdaq:NRXP) Announces Final Clinical Trial Results: Superior Safety Combined with Similar Efficacy in the Trial of NRX-101 Compared to Lurasidone in Suicidal Bipolar Depression https://finance.yahoo.com/news/nrx-pharmaceuticals-nasdaq-nrxp-announces-1
BMY JNJ LILY
100lbStriper 100lbStriper 5 minutes ago
2pm pacific, found it. boc pre
NLST
Runners123 Runners123 6 minutes ago
XBP news $40mil contract over several years bg holder alert most likely
Runners123 Runners123 6 minutes ago
XBP news $40mil contract over several years bg holder alert most likely
rhallzng rhallzng 6 minutes ago
Ok so those links all go to different media types ie X, Instagram and the contact us link on their Epiphany Cafe site...those hyper links all work...no the top one is a non clickable email address. These people's attempt at being internet-savvy is a huge fail....I have emailed them several times abo
SFIO
glenn1919 glenn1919 6 minutes ago
TCBP...................CUTR..........................MULN....................https://twitter.com/TGS_Trades/status/1786715926806614270
CUTR MULN TCBP
Paulness Paulness 6 minutes ago
OpRegen® (RG6501) Phase 1/2a Clinical Study 24-Month Visual Acuity Results Featured at 2024 Retinal Cell & Gene Therapy Innovation Summit

https://media.zenfs.com/en/business-wire.com/509e4412be44c5c9855fba73766fd421

BCVA gains of +5.5 letters at 24 months in Cohort
AMD LCTX
trader_ron trader_ron 6 minutes ago
$VPRB News- Turning Point Brands Canada Named Exclusive Master Distributor for VPR Brands' HoneyStick in Canada

A New Era for HoneyStick in Canada, TPB Canada’s Stewardship Includes Icons Such as Zig-Zag, Clipper, Choice Leaf, HMP, Rebound and Evolve

https://www.otcmark
VPRB
trader_ron trader_ron 6 minutes ago
$VPRB News- Turning Point Brands Canada Named Exclusive Master Distributor for VPR Brands' HoneyStick in Canada

A New Era for HoneyStick in Canada, TPB Canada’s Stewardship Includes Icons Such as Zig-Zag, Clipper, Choice Leaf, HMP, Rebound and Evolve

https://www.otcmark
VPRB
Porgie Tirebiter Porgie Tirebiter 7 minutes ago
Eagles have made a strong comeback in Illinois. I see them pretty regularly along the Fox river and it’s tributary’s. And if you go down to the Illinois river, you’re just about guaranteed to spot them.
novicetrader novicetrader 7 minutes ago
oh, got it, thanks. Wasn't aware of this name,lol!
Golden Cross Golden Cross 7 minutes ago
💲$RDAR targeting .002 with news on the way this week

https://twitter.com/raadr_/status/1786422034773455261
RDAR
Leandroi2002 Leandroi2002 7 minutes ago
News out
$IQST - iQSTEL Announces $27M In Revenue for the Month of April; Company Could Surpass $250M in Revenue for FY 2024
https://www.prnewswire.com/news-releases/iqst--iqstel-announces-27m-in-revenue-for-the-month-of-april-company-could-surpass-250m-in-revenue-for-fy-2024-302136686
IQST
100lbStriper 100lbStriper 7 minutes ago
robcobb
5:34 AM

$NLST Very important Samsung pre-trial today.The guidelines for the trial,and what can and can’t be argued at trial will be decided today starting at 2:00 pm Pacific time.What is very interesting is Michael Yoder is still on the list of lawyers to be present!Cou
NLST
sharkey1 sharkey1 7 minutes ago
Jimmy Joe. I don't see Naltrex on the FDA shortage list

https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Naltrexone%20Hydrochloride%20Tablet&st=c&tab=tabs-1

could be a logistic problem
ELTP
SEV123 SEV123 8 minutes ago
I was told they shunned a firm when share price was in the .50s because it was a bad deal. How is this any better? I guess we will see another reverse split? What will be the number of total shares now?
SEV
stockgringo stockgringo 8 minutes ago
https://healthstockshub.com/news/nasdaq/jagx/crofelemer-jaguar-health-s-prescription-drug-conditionally-approved-by-the-fda-for-chemotherapy-induced-diarrhea-in-dogs-is-the-subject-of-the-company-s-investigational-new-animal-drug-application-for-the-indication-of-general-diarrhea-in-dogs
JAGX
Golden Cross Golden Cross 8 minutes ago
💲$RDAR targeting .002 with news on the way this week

https://twitter.com/raadr_/status/1786422034773455261
RDAR
timberwolf7 timberwolf7 8 minutes ago
What will the commie partys new epa regs COST AMERICA/AMERICANS?? The question that needs to be asked is, WHO will be the big benefactors from this latest BS from our fed 'gov't'.. Just like covid, just like the war in ukraine, WHO is behind it, WHO are getting wealthy off of it.. Cause it usure
DJT
Hulk Hogan is God Hulk Hogan is God 8 minutes ago
No, I don’t think the CEO is on steroids.
That would give him some sort of an edge against the competition! This guy is knee deep in delisting notifications, non reported lower earnings, and major metro police departments cancelling Bolawrap programs!

Can we GET him some “as
WRAP

Your Recent History

EU
RCO
Remy Cointreau
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved